Terug
35
23
Ook genoteerd als
TMICY
OTC
Dagbereik
€ 33,10
€ 36,19
52-Weeksbereik
€ 33,10
€ 71,79
Volume
4.400
50D / 200D Gem.
€ 39,10
/
€ 51,99
Vorige Slotkoers
€ 33,10
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (621 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 12,5 |
| P/B | 0,0 | 2,9 |
| ROE % | 27,6 | 8,9 |
| Net Margin % | 12,5 | 5,6 |
| Rev Growth 5Y % | 9,8 | 9,2 |
| D/E | 0,0 | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 452,06
€ 422,18 – € 473,91
|
359,18B | 5 |
| FY2029 |
€ 406,76
€ 379,88 – € 426,43
|
341,56B | 2 |
| FY2028 |
€ 382,32
€ 357,05 – € 400,80
|
330,26B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-18 | € 49,92 | € 0,37 | -99,3% |
| 2025-08-07 | € 0,52 | € 41,33 | +7848,1% |
| 2025-05-06 | € 0,51 | € 0,46 | -9,6% |
| 2025-02-18 | € 0,36 | € 0,41 | +11,6% |
| 2024-11-12 | € 74,59 | € 65,33 | -12,4% |
| 2024-08-08 | € 65,85 | € 53,61 | -18,6% |
| 2024-05-08 | € 64,17 | € 79,31 | +23,6% |
| 2024-02-15 | € 42,47 | -€ 15,31 | -136,0% |
Dividend History
7 yr streakYield
0,03%
Payout Ratio
0,68%
Growth (3Y)
-3,62%
Growth (5Y)
-7,11%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 31, 2025 | Mar 27, 2026 | € 1,02 | 2,48% |
| Dec 31, 2024 | Mar 28, 2025 | € 1,17 | 2,03% |
| Dec 28, 2023 | Mar 29, 2024 | € 5,23 | 9,43% |
| Dec 29, 2022 | Mar 29, 2023 | € 1,14 | 2,52% |
| Dec 29, 2021 | Mar 30, 2022 | € 1,69 | 2,96% |
| Dec 29, 2020 | Mar 26, 2021 | € 1,48 | 2,75% |
| Dec 27, 2019 | Mar 27, 2020 | € 1,47 | 3,16% |
| Dec 26, 2018 | Mar 27, 2019 | € 1,48 | 2,51% |
| Dec 27, 2017 | Mar 28, 2018 | € 1,32 | 2,43% |
| Dec 28, 2016 | Mar 29, 2017 | € 1,20 | 3,34% |
| Dec 28, 2015 | Mar 28, 2016 | € 0,91 | 2,23% |
| Dec 26, 2014 | Mar 27, 2015 | € 0,96 | 3,25% |
| Dec 26, 2013 | Mar 27, 2014 | € 1,19 | 3,36% |
| Dec 26, 2012 | Mar 27, 2013 | € 0,78 | 2,79% |
| Dec 28, 2011 | Mar 28, 2012 | € 1,10 | 3,51% |
| Dec 28, 2010 | Mar 28, 2011 | € 0,85 | 2,56% |
| Dec 28, 2009 | Mar 29, 2010 | € 0,99 | 2,79% |
| Dec 25, 2008 | Mar 26, 2009 | € 1,07 | 3,63% |
| Dec 25, 2007 | Mar 27, 2008 | € 0,97 | 2,86% |
| Dec 26, 2006 | Mar 28, 2007 | € 0,71 | 2,38% |
Belangrijkste Punten
Revenue grew 9,75% annually over 5 years — modest growth
ROE of 27,62% indicates high profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 63,53B in free cash flow
P/E of 0,13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,43%
Groei
Revenue Growth (5Y)
9,75%
Revenue (1Y)1,32%
Earnings (1Y)0,57%
FCF Growth (3Y)43,47%
Kwaliteit
Return on Equity
27,62%
ROIC33,17%
Net Margin12,51%
Op. Margin20,93%
Veiligheid
Debt / Equity
0,00
Current Ratio1,19
Interest Coverage0,00
Waardering
P/E Ratio
0,13
Forward P/E0,11
P/B Ratio0,03
EV/EBITDA-3,73
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,32% | Revenue Growth (3Y) | 5,39% |
| Earnings Growth (1Y) | 0,57% | Earnings Growth (3Y) | 79,44% |
| Revenue Growth (5Y) | 9,75% | Earnings Growth (5Y) | -2,58% |
| Profitability | |||
| Revenue (TTM) | 276,22B | Net Income (TTM) | 34,55B |
| ROE | 27,62% | ROA | 8,18% |
| Gross Margin | 76,91% | Operating Margin | 20,93% |
| Net Margin | 12,51% | Free Cash Flow (TTM) | 63,53B |
| ROIC | 33,17% | FCF Growth (3Y) | 43,47% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 1,19 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | 0,68% |
| Dividend Growth (3Y) | -3,62% | Dividend Growth (5Y) | -7,11% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,13 | Forward P/E | 0,11 |
| P/B Ratio | 0,03 | P/S Ratio | 0,02 |
| PEG Ratio | 22,07 | Forward PEG | N/A |
| EV/EBITDA | -3,73 | Fwd EV/EBITDA | -2,59 |
| Forward P/S | 0,01 | Fwd Earnings Yield | 909,09% |
| FCF Yield | 1468,82% | ||
| Market Cap | 4,33B | Enterprise Value | -215,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 276,22B | 272,64B | 248,69B | 223,80B | 190,36B |
| Net Income | 34,55B | 34,36B | 10,73B | 29,84B | 38,37B |
| EPS (Diluted) | 260,37 | 257,66 | 78,38 | 213,21 | 275,06 |
| Gross Profit | 212,45B | 207,66B | 185,03B | 169,50B | 148,34B |
| Operating Income | 57,83B | 48,11B | 32,60B | 31,34B | 43,64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 422,61B | 400,32B | 492,63B | 470,80B | 420,46B |
| Total Liabilities | 291,37B | 280,87B | 278,21B | 242,12B | 199,03B |
| Shareholders' Equity | 130,74B | 119,45B | 214,39B | 228,66B | 220,64B |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 220,28B | 170,06B | 247,86B | 191,54B | 197,73B |
| Current Assets | 332,98B | 307,83B | 388,89B | 319,93B | 321,75B |
| Current Liabilities | 278,72B | 267,27B | 265,08B | 232,30B | 133,62B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#537 of 826
#178 of 203
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Ingestapt
Value Investing (Warren Buffett)
Mar 24, 2026
